Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Jun 15;101(12):2851–2861. doi: 10.1172/JCI1416

Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase-independent pathway.

R H Karas 1, E A Gauer 1, H E Bieber 1, W E Baur 1, M E Mendelsohn 1
PMCID: PMC508876  PMID: 9637719

Abstract

The classical estrogen receptor ERalpha mediates many of the known cardiovascular effects of estrogen and is expressed in male and female vascular cells. Estrogen-independent activation of ERalpha is known to occur in cells from reproductive tissues, but has not been investigated previously in vascular cells. In this study, transient transfection assays in human saphenous vein smooth muscle cells (HSVSMC) and pulmonary vein endothelial cells (PVEC) demonstrated ERalpha-dependent activation of estrogen response element-based, and vascular endothelial growth factor-based reporter plasmids by both estrogen-deficient FBS (ED-FBS) and EGF. In nonvascular cells, ERalpha-mediated gene expression can be activated via mitogen-activated protein (MAP) kinase- induced phosphorylation of serine 118 of ERalpha. However, in vascular cells, we found that pharmacologic inhibition of MAP kinase did not alter EGF-mediated ERalpha activation. In addition, a mutant ER containing an alanine-for-serine substitution at position 118 was activated to the same degree as the wild-type receptor by ED-FBS and EGF in both HSVSMC and PVEC. Furthermore, constitutively active MAP kinase kinase (MAPKK) activated ERalpha in Cos1 cells as expected, but MAPKK inhibited ER activation in PVEC. We conclude that growth factors also stimulate ERalpha-mediated gene expression in vascular cells, but find that this occurs via a MAP kinase-independent pathway distinct from that reported previously in nonvascular cells.

Full Text

The Full Text of this article is available as a PDF (427.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asahara T., Chen D., Tsurumi Y., Kearney M., Rossow S., Passeri J., Symes J. F., Isner J. M. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation. 1996 Dec 15;94(12):3291–3302. doi: 10.1161/01.cir.94.12.3291. [DOI] [PubMed] [Google Scholar]
  2. Baniahmad C., Nawaz Z., Baniahmad A., Gleeson M. A., Tsai M. J., O'Malley B. W. Enhancement of human estrogen receptor activity by SPT6: a potential coactivator. Mol Endocrinol. 1995 Jan;9(1):34–43. doi: 10.1210/mend.9.1.7760849. [DOI] [PubMed] [Google Scholar]
  3. Bhalla R. C., Toth K. F., Bhatty R. A., Thompson L. P., Sharma R. V. Estrogen reduces proliferation and agonist-induced calcium increase in coronary artery smooth muscle cells. Am J Physiol. 1997 Apr;272(4 Pt 2):H1996–H2003. doi: 10.1152/ajpheart.1997.272.4.H1996. [DOI] [PubMed] [Google Scholar]
  4. Blumenthal R. S., Heldman A. W., Brinker J. A., Resar J. R., Coombs V. J., Gloth S. T., Gerstenblith G., Reis S. E. Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men. Am J Cardiol. 1997 Oct 15;80(8):1021–1024. doi: 10.1016/s0002-9149(97)00596-1. [DOI] [PubMed] [Google Scholar]
  5. Bourassa P. A., Milos P. M., Gaynor B. J., Breslow J. L., Aiello R. J. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10022–10027. doi: 10.1073/pnas.93.19.10022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brogi E., Wu T., Namiki A., Isner J. M. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation. 1994 Aug;90(2):649–652. doi: 10.1161/01.cir.90.2.649. [DOI] [PubMed] [Google Scholar]
  7. Brown P. J., Schonbrunn A. Affinity purification of a somatostatin receptor-G-protein complex demonstrates specificity in receptor-G-protein coupling. J Biol Chem. 1993 Mar 25;268(9):6668–6676. [PubMed] [Google Scholar]
  8. Bunone G., Briand P. A., Miksicek R. J., Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 1996 May 1;15(9):2174–2183. [PMC free article] [PubMed] [Google Scholar]
  9. Bush T. L., Barrett-Connor E., Cowan L. D., Criqui M. H., Wallace R. B., Suchindran C. M., Tyroler H. A., Rifkind B. M. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987 Jun;75(6):1102–1109. doi: 10.1161/01.cir.75.6.1102. [DOI] [PubMed] [Google Scholar]
  10. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996 Apr 4;380(6573):435–439. doi: 10.1038/380435a0. [DOI] [PubMed] [Google Scholar]
  11. Caulin-Glaser T., García-Cardeña G., Sarrel P., Sessa W. C., Bender J. R. 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. Circ Res. 1997 Nov;81(5):885–892. doi: 10.1161/01.res.81.5.885. [DOI] [PubMed] [Google Scholar]
  12. Caulin-Glaser T., Watson C. A., Pardi R., Bender J. R. Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest. 1996 Jul 1;98(1):36–42. doi: 10.1172/JCI118774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cavaillès V., Dauvois S., Danielian P. S., Parker M. G. Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10009–10013. doi: 10.1073/pnas.91.21.10009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cavaillès V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P. J., Parker M. G. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 1995 Aug 1;14(15):3741–3751. doi: 10.1002/j.1460-2075.1995.tb00044.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chakravarti D., LaMorte V. J., Nelson M. C., Nakajima T., Schulman I. G., Juguilon H., Montminy M., Evans R. M. Role of CBP/P300 in nuclear receptor signalling. Nature. 1996 Sep 5;383(6595):99–103. doi: 10.1038/383099a0. [DOI] [PubMed] [Google Scholar]
  16. Chang W. C., Nakao J., Orimo H., Murota S. I. Stimulation of prostaglandin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells. Biochim Biophys Acta. 1980 Dec 5;620(3):472–482. [PubMed] [Google Scholar]
  17. Chen J. D., Evans R. M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 1995 Oct 5;377(6548):454–457. doi: 10.1038/377454a0. [DOI] [PubMed] [Google Scholar]
  18. Chen J. D., Umesono K., Evans R. M. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7567–7571. doi: 10.1073/pnas.93.15.7567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chen S. J., Li H., Durand J., Oparil S., Chen Y. F. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 1996 Feb 1;93(3):577–584. doi: 10.1161/01.cir.93.3.577. [DOI] [PubMed] [Google Scholar]
  20. Colditz G. A., Willett W. C., Stampfer M. J., Rosner B., Speizer F. E., Hennekens C. H. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987 Apr 30;316(18):1105–1110. doi: 10.1056/NEJM198704303161801. [DOI] [PubMed] [Google Scholar]
  21. Collins P., Shay J., Jiang C., Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation. 1994 Oct;90(4):1964–1968. doi: 10.1161/01.cir.90.4.1964. [DOI] [PubMed] [Google Scholar]
  22. Cullinan-Bove K., Koos R. D. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology. 1993 Aug;133(2):829–837. doi: 10.1210/endo.133.2.8344219. [DOI] [PubMed] [Google Scholar]
  23. Eddy E. M., Washburn T. F., Bunch D. O., Goulding E. H., Gladen B. C., Lubahn D. B., Korach K. S. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology. 1996 Nov;137(11):4796–4805. doi: 10.1210/endo.137.11.8895349. [DOI] [PubMed] [Google Scholar]
  24. El-Tanani M. K., Green C. D. Two separate mechanisms for ligand-independent activation of the estrogen receptor. Mol Endocrinol. 1997 Jun;11(7):928–937. doi: 10.1210/mend.11.7.9939. [DOI] [PubMed] [Google Scholar]
  25. Evans R. M. The steroid and thyroid hormone receptor superfamily. Science. 1988 May 13;240(4854):889–895. doi: 10.1126/science.3283939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K. S., Powell-Braxton L., Hillan K. J., Moore M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996 Apr 4;380(6573):439–442. doi: 10.1038/380439a0. [DOI] [PubMed] [Google Scholar]
  27. Ferrara N., Winer J., Burton T. Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors. 1991;5(2):141–148. doi: 10.3109/08977199109000278. [DOI] [PubMed] [Google Scholar]
  28. Fischer-Dzoga K., Wissler R. W., Vesselinovitch D. The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipemic serum. Exp Mol Pathol. 1983 Dec;39(3):355–363. doi: 10.1016/0014-4800(83)90064-3. [DOI] [PubMed] [Google Scholar]
  29. Fox J. C., Swain J. L. Angiogenic gene therapy. A leg to stand on? Circulation. 1996 Dec 15;94(12):3065–3066. doi: 10.1161/01.cir.94.12.3065. [DOI] [PubMed] [Google Scholar]
  30. Gebara O. C., Mittleman M. A., Sutherland P., Lipinska I., Matheney T., Xu P., Welty F. K., Wilson P. W., Levy D., Muller J. E. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation. 1995 Apr 1;91(7):1952–1958. doi: 10.1161/01.cir.91.7.1952. [DOI] [PubMed] [Google Scholar]
  31. Glass C. K., Holloway J. M., Devary O. V., Rosenfeld M. G. The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell. 1988 Jul 29;54(3):313–323. doi: 10.1016/0092-8674(88)90194-8. [DOI] [PubMed] [Google Scholar]
  32. Gotoh Y., Matsuda S., Takenaka K., Hattori S., Iwamatsu A., Ishikawa M., Kosako H., Nishida E. Characterization of recombinant Xenopus MAP kinase kinases mutated at potential phosphorylation sites. Oncogene. 1994 Jul;9(7):1891–1898. [PubMed] [Google Scholar]
  33. Grady D., Rubin S. M., Petitti D. B., Fox C. S., Black D., Ettinger B., Ernster V. L., Cummings S. R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992 Dec 15;117(12):1016–1037. doi: 10.7326/0003-4819-117-12-1016. [DOI] [PubMed] [Google Scholar]
  34. Green S., Walter P., Kumar V., Krust A., Bornert J. M., Argos P., Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986 Mar 13;320(6058):134–139. doi: 10.1038/320134a0. [DOI] [PubMed] [Google Scholar]
  35. Gu W., Shi X. L., Roeder R. G. Synergistic activation of transcription by CBP and p53. Nature. 1997 Jun 19;387(6635):819–823. doi: 10.1038/42972. [DOI] [PubMed] [Google Scholar]
  36. Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C., Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science. 1994 Jun 3;264(5164):1455–1458. doi: 10.1126/science.8197458. [DOI] [PubMed] [Google Scholar]
  37. Hanstein B., Eckner R., DiRenzo J., Halachmi S., Liu H., Searcy B., Kurokawa R., Brown M. p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11540–11545. doi: 10.1073/pnas.93.21.11540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Hess R. A., Bunick D., Lee K. H., Bahr J., Taylor J. A., Korach K. S., Lubahn D. B. A role for oestrogens in the male reproductive system. Nature. 1997 Dec 4;390(6659):509–512. doi: 10.1038/37352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Hörlein A. J., När A. M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Söderström M., Glass C. K. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature. 1995 Oct 5;377(6548):397–404. doi: 10.1038/377397a0. [DOI] [PubMed] [Google Scholar]
  40. Ignar-Trowbridge D. M., Nelson K. G., Bidwell M. C., Curtis S. W., Washburn T. F., McLachlan J. A., Korach K. S. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4658–4662. doi: 10.1073/pnas.89.10.4658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ignar-Trowbridge D. M., Teng C. T., Ross K. A., Parker M. G., Korach K. S., McLachlan J. A. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol. 1993 Aug;7(8):992–998. doi: 10.1210/mend.7.8.8232319. [DOI] [PubMed] [Google Scholar]
  42. Ignar-Trowbridge D. M., Teng C. T., Ross K. A., Parker M. G., Korach K. S., McLachlan J. A. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol. 1993 Aug;7(8):992–998. doi: 10.1210/mend.7.8.8232319. [DOI] [PubMed] [Google Scholar]
  43. Janknecht R., Hunter T. Transcription. A growing coactivator network. Nature. 1996 Sep 5;383(6595):22–23. doi: 10.1038/383022a0. [DOI] [PubMed] [Google Scholar]
  44. Jiang C. W., Sarrel P. M., Lindsay D. C., Poole-Wilson P. A., Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br J Pharmacol. 1991 Dec;104(4):1033–1037. doi: 10.1111/j.1476-5381.1991.tb12545.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Jiang C., Sarrel P. M., Poole-Wilson P. A., Collins P. Acute effect of 17 beta-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol. 1992 Jul;263(1 Pt 2):H271–H275. doi: 10.1152/ajpheart.1992.263.1.H271. [DOI] [PubMed] [Google Scholar]
  46. Karas R. H., Patterson B. L., Mendelsohn M. E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 1994 May;89(5):1943–1950. doi: 10.1161/01.cir.89.5.1943. [DOI] [PubMed] [Google Scholar]
  47. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 1995 Dec 1;270(5241):1491–1494. doi: 10.1126/science.270.5241.1491. [DOI] [PubMed] [Google Scholar]
  48. Kim-Schulze S., McGowan K. A., Hubchak S. C., Cid M. C., Martin M. B., Kleinman H. K., Greene G. L., Schnaper H. W. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation. 1996 Sep 15;94(6):1402–1407. doi: 10.1161/01.cir.94.6.1402. [DOI] [PubMed] [Google Scholar]
  49. King R. J. Structure and function of steroid receptors. J Endocrinol. 1987 Sep;114(3):341–349. doi: 10.1677/joe.0.1140341. [DOI] [PubMed] [Google Scholar]
  50. Koike H., Karas R. H., Baur W. E., O'Donnell T. F., Jr, Mendelsohn M. E. Differential-display polymerase chain reaction identifies nucleophosmin as an estrogen-regulated gene in human vascular smooth muscle cells. J Vasc Surg. 1996 Mar;23(3):477–482. doi: 10.1016/s0741-5214(96)80014-0. [DOI] [PubMed] [Google Scholar]
  51. Kolodgie F. D., Jacob A., Wilson P. S., Carlson G. C., Farb A., Verma A., Virmani R. Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. Am J Pathol. 1996 Mar;148(3):969–976. [PMC free article] [PubMed] [Google Scholar]
  52. Krasinski K., Spyridopoulos I., Asahara T., van der Zee R., Isner J. M., Losordo D. W. Estradiol accelerates functional endothelial recovery after arterial injury. Circulation. 1997 Apr 1;95(7):1768–1772. doi: 10.1161/01.cir.95.7.1768. [DOI] [PubMed] [Google Scholar]
  53. Kunkel T. A., Roberts J. D., Zakour R. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 1987;154:367–382. doi: 10.1016/0076-6879(87)54085-x. [DOI] [PubMed] [Google Scholar]
  54. Kurokawa R., Söderström M., Hörlein A., Halachmi S., Brown M., Rosenfeld M. G., Glass C. K. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature. 1995 Oct 5;377(6548):451–454. doi: 10.1038/377451a0. [DOI] [PubMed] [Google Scholar]
  55. Lantin-Hermoso R. L., Rosenfeld C. R., Yuhanna I. S., German Z., Chen Z., Shaul P. W. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol. 1997 Jul;273(1 Pt 1):L119–L126. doi: 10.1152/ajplung.1997.273.1.L119. [DOI] [PubMed] [Google Scholar]
  56. Levy A. P., Levy N. S., Wegner S., Goldberg M. A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem. 1995 Jun 2;270(22):13333–13340. doi: 10.1074/jbc.270.22.13333. [DOI] [PubMed] [Google Scholar]
  57. Libby P., O'Brien K. V. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J Cell Physiol. 1983 May;115(2):217–223. doi: 10.1002/jcp.1041150217. [DOI] [PubMed] [Google Scholar]
  58. Lill N. L., Grossman S. R., Ginsberg D., DeCaprio J., Livingston D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature. 1997 Jun 19;387(6635):823–827. doi: 10.1038/42981. [DOI] [PubMed] [Google Scholar]
  59. Losordo D. W., Kearney M., Kim E. A., Jekanowski J., Isner J. M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 1994 Apr;89(4):1501–1510. doi: 10.1161/01.cir.89.4.1501. [DOI] [PubMed] [Google Scholar]
  60. Lubahn D. B., Moyer J. S., Golding T. S., Couse J. F., Korach K. S., Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11162–11166. doi: 10.1073/pnas.90.23.11162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Majesky M. W. A little VEGF goes a long way. Therapeutic angiogenesis by direct injection of vascular endothelial growth factor-encoding plasmid DNA. Circulation. 1996 Dec 15;94(12):3062–3064. doi: 10.1161/01.cir.94.12.3062. [DOI] [PubMed] [Google Scholar]
  62. McCrohon J. A., Walters W. A., Robinson J. T., McCredie R. J., Turner L., Adams M. R., Handelsman D. J., Celermajer D. S. Arterial reactivity is enhanced in genetic males taking high dose estrogens. J Am Coll Cardiol. 1997 Jun;29(7):1432–1436. doi: 10.1016/s0735-1097(97)00063-6. [DOI] [PubMed] [Google Scholar]
  63. McDonnell D. P., Clemm D. L., Hermann T., Goldman M. E., Pike J. W. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol. 1995 Jun;9(6):659–669. doi: 10.1210/mend.9.6.8592512. [DOI] [PubMed] [Google Scholar]
  64. McInerney E. M., Tsai M. J., O'Malley B. W., Katzenellenbogen B. S. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10069–10073. doi: 10.1073/pnas.93.19.10069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Mendelsohn M. E., Karas R. H. Estrogen and the blood vessel wall. Curr Opin Cardiol. 1994 Sep;9(5):619–626. doi: 10.1097/00001573-199409000-00018. [DOI] [PubMed] [Google Scholar]
  66. Metzger D., Berry M., Ali S., Chambon P. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol Endocrinol. 1995 May;9(5):579–591. doi: 10.1210/mend.9.5.7565805. [DOI] [PubMed] [Google Scholar]
  67. Morales D. E., McGowan K. A., Grant D. S., Maheshwari S., Bhartiya D., Cid M. C., Kleinman H. K., Schnaper H. W. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation. 1995 Feb 1;91(3):755–763. doi: 10.1161/01.cir.91.3.755. [DOI] [PubMed] [Google Scholar]
  68. Nabulsi A. A., Folsom A. R., White A., Patsch W., Heiss G., Wu K. K., Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med. 1993 Apr 15;328(15):1069–1075. doi: 10.1056/NEJM199304153281501. [DOI] [PubMed] [Google Scholar]
  69. New G., Timmins K. L., Duffy S. J., Tran B. T., O'Brien R. C., Harper R. W., Meredith I. T. Long-term estrogen therapy improves vascular function in male to female transsexuals. J Am Coll Cardiol. 1997 Jun;29(7):1437–1444. doi: 10.1016/s0735-1097(97)00080-6. [DOI] [PubMed] [Google Scholar]
  70. Ogawa S., Lubahn D. B., Korach K. S., Pfaff D. W. Behavioral effects of estrogen receptor gene disruption in male mice. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1476–1481. doi: 10.1073/pnas.94.4.1476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Ogawa S., Lubahn D. B., Korach K. S., Pfaff D. W. Behavioral effects of estrogen receptor gene disruption in male mice. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1476–1481. doi: 10.1073/pnas.94.4.1476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Orimo A., Inoue S., Ikegami A., Hosoi T., Akishita M., Ouchi Y., Muramatsu M., Orimo H. Vascular smooth muscle cells as target for estrogen. Biochem Biophys Res Commun. 1993 Sep 15;195(2):730–736. doi: 10.1006/bbrc.1993.2106. [DOI] [PubMed] [Google Scholar]
  73. Oñate S. A., Tsai S. Y., Tsai M. J., O'Malley B. W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 1995 Nov 24;270(5240):1354–1357. doi: 10.1126/science.270.5240.1354. [DOI] [PubMed] [Google Scholar]
  74. Power R. F., Mani S. K., Codina J., Conneely O. M., O'Malley B. W. Dopaminergic and ligand-independent activation of steroid hormone receptors. Science. 1991 Dec 13;254(5038):1636–1639. doi: 10.1126/science.1749936. [DOI] [PubMed] [Google Scholar]
  75. Redmond E. M., Cherian M. N., Wetzel R. C. 17 beta-Estradiol inhibits flow- and acute hypoxia-induced prostacyclin release from perfused endocardial endothelial cells. Circulation. 1994 Nov;90(5):2519–2524. doi: 10.1161/01.cir.90.5.2519. [DOI] [PubMed] [Google Scholar]
  76. Reis S. E., Gloth S. T., Blumenthal R. S., Resar J. R., Zacur H. A., Gerstenblith G., Brinker J. A. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 1994 Jan;89(1):52–60. doi: 10.1161/01.cir.89.1.52. [DOI] [PubMed] [Google Scholar]
  77. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992 Oct 29;359(6398):843–845. doi: 10.1038/359843a0. [DOI] [PubMed] [Google Scholar]
  78. Smith C. L., Oñate S. A., Tsai M. J., O'Malley B. W. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8884–8888. doi: 10.1073/pnas.93.17.8884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Smith E. P., Boyd J., Frank G. R., Takahashi H., Cohen R. M., Specker B., Williams T. C., Lubahn D. B., Korach K. S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994 Oct 20;331(16):1056–1061. doi: 10.1056/NEJM199410203311604. [DOI] [PubMed] [Google Scholar]
  80. Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med. 1991 Sep 12;325(11):756–762. doi: 10.1056/NEJM199109123251102. [DOI] [PubMed] [Google Scholar]
  81. Sudhir K., Chou T. M., Messina L. M., Hutchison S. J., Korach K. S., Chatterjee K., Rubanyi G. M. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet. 1997 Apr 19;349(9059):1146–1147. doi: 10.1016/S0140-6736(05)63022-X. [DOI] [PubMed] [Google Scholar]
  82. Trowbridge J. M., Rogatsky I., Garabedian M. J. Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex. Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10132–10137. doi: 10.1073/pnas.94.19.10132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Tsurumi Y., Takeshita S., Chen D., Kearney M., Rossow S. T., Passeri J., Horowitz J. R., Symes J. F., Isner J. M. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 1996 Dec 15;94(12):3281–3290. doi: 10.1161/01.cir.94.12.3281. [DOI] [PubMed] [Google Scholar]
  84. Tzukerman M. T., Esty A., Santiso-Mere D., Danielian P., Parker M. G., Stein R. B., Pike J. W., McDonnell D. P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol. 1994 Jan;8(1):21–30. doi: 10.1210/mend.8.1.8152428. [DOI] [PubMed] [Google Scholar]
  85. Vargas R., Wroblewska B., Rego A., Hatch J., Ramwell P. W. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol. 1993 Jul;109(3):612–617. doi: 10.1111/j.1476-5381.1993.tb13616.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Venkov C. D., Rankin A. B., Vaughan D. E. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation. 1996 Aug 15;94(4):727–733. doi: 10.1161/01.cir.94.4.727. [DOI] [PubMed] [Google Scholar]
  87. Weiner C. P., Lizasoain I., Baylis S. A., Knowles R. G., Charles I. G., Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A. 1994 May 24;91(11):5212–5216. doi: 10.1073/pnas.91.11.5212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. White R. E., Darkow D. J., Lang J. L. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. Circ Res. 1995 Nov;77(5):936–942. doi: 10.1161/01.res.77.5.936. [DOI] [PubMed] [Google Scholar]
  89. Williams J. K., Adams M. R., Herrington D. M., Clarkson T. B. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 1992 Aug;20(2):452–457. doi: 10.1016/0735-1097(92)90116-5. [DOI] [PubMed] [Google Scholar]
  90. Williams J. K., Adams M. R., Klopfenstein H. S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990 May;81(5):1680–1687. doi: 10.1161/01.cir.81.5.1680. [DOI] [PubMed] [Google Scholar]
  91. Zhang F., Ram J. L., Standley P. R., Sowers J. R. 17 beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol. 1994 Apr;266(4 Pt 1):C975–C980. doi: 10.1152/ajpcell.1994.266.4.C975. [DOI] [PubMed] [Google Scholar]
  92. Zwijsen R. M., Wientjens E., Klompmaker R., van der Sman J., Bernards R., Michalides R. J. CDK-independent activation of estrogen receptor by cyclin D1. Cell. 1997 Feb 7;88(3):405–415. doi: 10.1016/s0092-8674(00)81879-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES